Resources

This poster describes the AV Avantage HPV E6 Test and the results from a small clinical pilot study. The AV Avantage HPV E6 Test uses high affinity mAb for the specific capture and detection of high-risk HPV-E6 oncoproteins in a lateral flow–based format. Presented at: 26th International Papillomavirus Conference, July 3, 2010; Montreal, Canada.

Human papillomavirus (HPV) vaccine is intended to prevent cervical cancer. As part of project Optimize, a two-year HPV vaccine demonstration project is being conducted to demonstrate how existing delivery systems can be adapted to successfully provide HPV vaccine to young adolescent girls. HPV vaccine is a strong candidate for out-of-the-cold-chain use given its characteristics of high heat stability and freeze sensitivity.

PATH conducted a market study in 2008 to identify neonatal resuscitators available in the Southern African Development Community region. These resuscitators are included in this region-specific version of Practical Selection of Neonatal Resuscitators. All resuscitators identified were bag-and-mask designs. Also included are two devices that offer a tube-and-mask design. This guide presents the criteria used during the device evaluation, evaluation results for each device, and suggestions for choosing a resuscitator. The guide is available in two formats: one for booklet-style printing and one for onscreen viewing.

This handbook is a practical guide developed for site-level microbicide researchers, communicators, advocates, and others working on HIV prevention trials in developing countries. It includes context-specific case studies and practical insights from actual clinical trial communications initiatives. It is being updated to include work sheets and slide sets. To apply for a complimentary copy, please email Jacqueline Borodan at jacqueline@avac.org for detailed instructions.

This report covers a 2009 consultation in Kampala, Uganda, that was convened by the Global Campaign for Microbicides, the Joint UN Programme on HIV/AIDS, and the US Centers for Disease Control and Prevention. It includes recommendations related to key ethical and practical questions on the design and implementation of clinical trials.